covid 19 News and Research

RSS

Why the form of vitamin B12 you take may matter more than your intake

This comprehensive review examines vitamin B12 absorption, physiological roles, deficiency states, and dietary sources, with particular attention to differences between natural and synthetic forms. The authors conclude that while all B12 forms raise circulating levels, methylcobalamin may offer advantages in specific clinical contexts, especially where absorption or metabolic conversion is impaired.

10 Dec 2025

Researchers unravel why mRNA-based vaccines for COVID-19 can cause heart damage

Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause heart damage in some young men and adolescents - and they've shown a possible route to reducing its likelihood.

10 Dec 2025

VALANX Biotech establishes Board of Directors

VALANX Biotech (VALANX), a biotech company developing novel antibody-drug-conjugate (ADC) assets enabled by its GoldenSite™ site-specific protein conjugation technology, today announced the formation of its Board of Directors.

10 Dec 2025

Research ushers in a new era of hope for patients with primary immune thrombocytopenia

More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune disorder that can cause life-threatening bleeding, were able to maintain safe platelet counts without serious bleeding episodes for at least one year.

9 Dec 2025

High BMI and poor physical fitness in adolescence linked to severe bacterial infections in adulthood

High BMI and poor physical fitness during later adolescence increase the risk of both contracting and dying from sepsis and other severe bacterial infections in adulthood, according to a study from the University of Gothenburg.

9 Dec 2025

Older chemical libraries yield new leads for next-generation COVID-19 antivirals

SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid.

8 Dec 2025

Serious side effects after CAR T cell therapy for multiple myeloma share a common immune root cause

Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive CAR T cell therapy for multiple myeloma share a common immune root cause, are associated with high rates of death unrelated to cancer relapse-primarily infection-and may be avoidable.

8 Dec 2025

Young Australians are staying on antidepressants for longer than ever

Long-term antidepressant use in Australia increased steadily between 2014 and 2023, with the largest relative rise seen among adolescents and young adults aged 10 to 24 years. Treatment duration also lengthened over time, while apparent dose reduction efforts remained limited, raising concerns about deprescribing practices.

7 Dec 2025

Where you live affects your weight more than you think

Findings reveal a strong link between location and Body Mass Index, emphasizing the need for policies addressing food environments and health disparities.

4 Dec 2025

NeuMap unveils the hidden architecture and life-long patterns of human neutrophils

Neutrophils are the most abundant immune cells in the body and the first to respond to infection or tissue damage.

3 Dec 2025

Americans trust AMA over CDC on vaccine safety

For decades, health-related statements by major professional health associations such as the American Medical Association (AMA) agreed with those of the Centers for Disease Control and Prevention (CDC) because both relied on the same body of scientific knowledge, much of it funded by the federal health sector.

3 Dec 2025

Study finds sharp rise in long-term antidepressant use among young Australians

Long-term antidepressant use in Australia has risen steadily over the past decade, with the largest increase seen in young people aged 10-24, where rates have more than doubled.

2 Dec 2025

Worldwide smell screening could improve mental and physical health of millions

A programme of smell screening, awareness campaigns and health policies could improve the mental and physical health of millions - according to research led by the University of East Anglia.

1 Dec 2025

Measles deaths plummet but infections surge worldwide

Global immunization efforts have led to an 88% drop in measles deaths between 2000 and 2024, according to a new report from the World Health Organization (WHO). Nearly 59 million lives have been saved by the measles vaccine since 2000.

29 Nov 2025

Long COVID symptoms change for 15 months after infection

Long COVID shows varied recovery trajectories, with distinct symptom patterns identified in the RECOVER cohort, emphasizing the need for personalized care.

28 Nov 2025

Study finds major setbacks in blood pressure prevention and management in England

A comprehensive new analysis by researchers at Queen Mary University of London warns that England has lost the substantial gains made in high blood pressure prevention, diagnosis and management during the 2000s.

27 Nov 2025

Tattoo ink alters immune cells and weakens some vaccine responses

New research shows tattoo pigments migrate to lymph nodes, causing inflammation and altering immune responses to vaccines, with potential health risks.

27 Nov 2025

Pandemic lockdown measures linked to increased developmental concerns in young children

Lockdown and social distancing measures during the Covid-19 pandemic were associated with increased developmental concerns about young children in Scotland, research suggests.

26 Nov 2025

Nontraditional benefits influence retention of younger government health employees

Younger workers in governmental public health place significantly higher value on nontraditional benefits than their older counterparts, according to a new study from Columbia University Mailman School of Public Health.

25 Nov 2025

Poor lung gas exchange may help explain lingering brain symptoms in Long COVID

This study found that people with Long COVID more than two years after infection showed normal lung tests and brain structure, yet reported significant sleep and cognitive symptoms. Subtle correlations revealed that poorer lung gas exchange was linked with higher brain perfusion, worse sleep, and weaker executive function, suggesting a possible lung–brain connection.

25 Nov 2025

Previous
1
...
23
24
25
26
27
28
29
...
1308
Next

covid 19 News and Research

Why the form of vitamin B12 you take may matter more than your intake

Researchers unravel why mRNA-based vaccines for COVID-19 can cause heart damage

VALANX Biotech establishes Board of Directors

Research ushers in a new era of hope for patients with primary immune thrombocytopenia

High BMI and poor physical fitness in adolescence linked to severe bacterial infections in adulthood

Older chemical libraries yield new leads for next-generation COVID-19 antivirals

Serious side effects after CAR T cell therapy for multiple myeloma share a common immune root cause

Young Australians are staying on antidepressants for longer than ever

Where you live affects your weight more than you think

NeuMap unveils the hidden architecture and life-long patterns of human neutrophils

Americans trust AMA over CDC on vaccine safety

Study finds sharp rise in long-term antidepressant use among young Australians

Worldwide smell screening could improve mental and physical health of millions

Measles deaths plummet but infections surge worldwide

Long COVID symptoms change for 15 months after infection

Study finds major setbacks in blood pressure prevention and management in England

Tattoo ink alters immune cells and weakens some vaccine responses

Pandemic lockdown measures linked to increased developmental concerns in young children

Nontraditional benefits influence retention of younger government health employees

Poor lung gas exchange may help explain lingering brain symptoms in Long COVID

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News